These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17554001)

  • 1. The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype.
    Aubrey KR; Rossi FM; Ruivo R; Alboni S; Bellenchi GC; Le Goff A; Gasnier B; Supplisson S
    J Neurosci; 2007 Jun; 27(23):6273-81. PubMed ID: 17554001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic ablation of VIAAT in glycinergic neurons causes a severe respiratory phenotype and perinatal death.
    Rahman J; Besser S; Schnell C; Eulenburg V; Hirrlinger J; Wojcik SM; Hülsmann S
    Brain Struct Funct; 2015 Sep; 220(5):2835-49. PubMed ID: 25027639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
    Rousseau F; Aubrey KR; Supplisson S
    J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic control of inhibitory neurotransmitter content in VIAAT containing synaptic vesicles.
    Aubrey KR
    Neurochem Int; 2016 Sep; 98():94-102. PubMed ID: 27296116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of the vesicular inhibitory amino acid transporter in GABAergic and glycinergic synaptic terminal boutons.
    Dumoulin A; Rostaing P; Bedet C; Lévi S; Isambert MF; Henry JP; Triller A; Gasnier B
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():811-23. PubMed ID: 10036231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of synaptic inhibition in glycine transporter 2 deficient mice.
    Latal AT; Kremer T; Gomeza J; Eulenburg V; Hülsmann S
    Mol Cell Neurosci; 2010 Aug; 44(4):342-52. PubMed ID: 20447457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shared vesicular carrier allows synaptic corelease of GABA and glycine.
    Wojcik SM; Katsurabayashi S; Guillemin I; Friauf E; Rosenmund C; Brose N; Rhee JS
    Neuron; 2006 May; 50(4):575-87. PubMed ID: 16701208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular inhibitory amino acid transporter is a Cl-/gamma-aminobutyrate Co-transporter.
    Juge N; Muroyama A; Hiasa M; Omote H; Moriyama Y
    J Biol Chem; 2009 Dec; 284(50):35073-8. PubMed ID: 19843525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GlyT1 determines the glycinergic phenotype of amacrine cells in the mouse retina.
    Eulenburg V; Knop G; Sedmak T; Schuster S; Hauf K; Schneider J; Feigenspan A; Joachimsthaler A; Brandstätter JH
    Brain Struct Funct; 2018 Sep; 223(7):3251-3266. PubMed ID: 29808289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Signaling at GABA and Glycine Co-releasing Terminals.
    Aubrey KR; Supplisson S
    Front Synaptic Neurosci; 2018; 10():40. PubMed ID: 30524262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct development of the glycinergic terminals in the ventral and dorsal horns of the mouse cervical spinal cord.
    Sunagawa M; Shimizu-Okabe C; Kim J; Kobayashi S; Kosaka Y; Yanagawa Y; Matsushita M; Okabe A; Takayama C
    Neuroscience; 2017 Feb; 343():459-471. PubMed ID: 28039040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine transporters: essential regulators of synaptic transmission.
    Betz H; Gomeza J; Armsen W; Scholze P; Eulenburg V
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):55-8. PubMed ID: 16417482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic regulation of glycine-GABA co-transmission at spinal inhibitory synapses by neuronal glutamate transporter.
    Ishibashi H; Yamaguchi J; Nakahata Y; Nabekura J
    J Physiol; 2013 Aug; 591(16):3821-32. PubMed ID: 23690564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of glycine transporters (xGlyT1, xGlyT2, and xVIAAT) in Xenopus laevis during early development.
    Wester MR; Teasley DC; Byers SL; Saha MS
    Gene Expr Patterns; 2008 Apr; 8(4):261-70. PubMed ID: 18262473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids.
    Gasnier B
    Pflugers Arch; 2004 Feb; 447(5):756-9. PubMed ID: 12750892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies.
    Zafra F; Ibáñez I; Giménez C
    Neuronal Signal; 2017 Feb; 1(1):NS20160009. PubMed ID: 32714574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive phosphorylation of the vesicular inhibitory amino acid transporter in rat central nervous system.
    Bedet C; Isambert MF; Henry JP; Gasnier B
    J Neurochem; 2000 Oct; 75(4):1654-63. PubMed ID: 10987847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologically identified glycinergic synapses in the hippocampus.
    Danglot L; Rostaing P; Triller A; Bessis A
    Mol Cell Neurosci; 2004 Dec; 27(4):394-403. PubMed ID: 15555918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular inhibitory amino acid transporter is present in glucagon-containing secretory granules in alphaTC6 cells, mouse clonal alpha-cells, and alpha-cells of islets of Langerhans.
    Hayashi M; Otsuka M; Morimoto R; Muroyama A; Uehara S; Yamamoto A; Moriyama Y
    Diabetes; 2003 Aug; 52(8):2066-74. PubMed ID: 12882924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.